[ Price : $8.95]
Three Hyman, Phelps attorneys say an HHS announcement withdrawing a Trump administration policy on FDA review of laboratory-develo...[ Price : $8.95]
FDA sends Fennec Pharmaceuticals a second complete response letter on its NDA for Pedmark (sodium thiosulfate, intravenous) for pr...[ Price : $8.95]
Federal Register notice: FDA requests nominations for voting members to serve on CDRHs Technical Electronic Product Radiation Safe...[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance on Real-World Data: Assessing Registries to Support Regulatory Decis...[ Price : $8.95]
Drug companies and other stakeholders respond to an FDA draft guidance on using electronic health records and claims data in real-...[ Price : $8.95]
Federal Register notice: FDA determines for patent extension purposes the regulatory review period for Pharma Mars Zepzelca (lurbi...[ Price : $8.95]
Federal Register notice: FDA seeks comments on an information collection revision entitled Prescription Drug User Fee Program.[ Price : $8.95]
FDA posts a draft guidance on Real-World Data: Assessing Registries to Support Regulatory Decision-Making for Drug and Biological ...